Frank A Holler Xenon Pharmaceuticals Inc. (XENE) insider trading activity

XENE Quotes by TradingView

Frank A Holler is Director of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 143,653 shares of XENE, which is worth approximately $5.72 Million. The most recent transaction as insider was on May 27, 2021, when has been sold 6,418 shares (Common Shares) at a price of $18.88 per share, resulting in proceeds of $121,172. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 144K
0% 3M change
0% 12M change
Total Value Held $5.72 Million

FRANK A HOLLER Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 27 2021
SELL
Payment of exercise price or tax liability
$121,172 $18.88 p/Share
6,418 Reduced 3.98%
154,717 Common Shares
May 27 2021
SELL
Open market or private sale
$206,786 $18.69 p/Share
11,064 Reduced 7.15%
143,653 Common Shares
May 27 2021
BUY
Exercise of conversion of derivative security
$146,993 $3.76 p/Share
39,094 Added 19.57%
160,628 Common Shares
FAH

Frank A Holler

Director
Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XENE